Cargando…

Neddylation inactivation represses androgen receptor transcription and inhibits growth, survival and invasion of prostate cancer cells

Androgen receptor (AR) and its constitutively active variants (AR-Vs) have been extensively implicated in the progression and recurrence of prostate cancer, making them attractive targets in the treatment of this disease. Whether and how neddylation modification regulates AR, and the therapeutic imp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Xiaochen, Han, Sumin, Wilder-Romans, Kari, Sun, Grace Y., Zhu, Hong, Liu, Xiaoqiang, Tan, Mingjia, Wang, Gongxian, Feng, Felix Y., Sun, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2020
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7058827/ https://www.ncbi.nlm.nih.gov/pubmed/32145689 http://dx.doi.org/10.1016/j.neo.2020.02.002

Ejemplares similares

Transcriptional repression by androgen receptor: roles in castration-resistant prostate cancer
por: Gritsina, Galina, et al.
Publicado: (2019)

Neddylation inhibitor MLN4924 suppresses cilia formation by modulating AKT1
por: Mao, Hongmei, et al.
Publicado: (2019)

Androgen receptor‐mediated transcriptional repression targets cell plasticity in prostate cancer
por: Erdmann, Éva, et al.
Publicado: (2022)

Assessment of oligometastasis status of prostate cancer following combined robot-assisted radical prostatectomy and androgen deprivation versus androgen deprivation therapy alone using PSA percentage decline rate
por: Li, Xuwen, et al.
Publicado: (2023)

Pevonedistat Suppresses Pancreatic Cancer Growth via Inactivation of the Neddylation Pathway
por: Xu, Junfeng, et al.
Publicado: (2022)

Tzfp Represses the Androgen Receptor in Mouse Testis
por: Furu, Kari, et al.
Publicado: (2013)

Androgen receptor degraders overcome common resistance mechanisms developed during prostate cancer treatment
por: Kregel, Steven, et al.
Publicado: (2020)

Expression of neddylation-related proteins in melanoma cell lines and the effect of neddylation on melanoma proliferation
por: CHENG, FANG, et al.
Publicado: (2014)

The slope associated with nadir prostate‐specific antigen is prognostically significant in men with hormone‐sensitive prostate cancer after primary androgen deprivation therapy
por: Zhenhao, Zeng, et al.
Publicado: (2022)

Targeting Protein Neddylation to Inactivate Cullin-RING Ligases by Gossypol: A Lucky Hit or a New Start?
por: Yu, Qing, et al.
Publicado: (2021)

Waking immune-resistant tumors with neddylation
por: Huntoon, Kristin, et al.
Publicado: (2023)

Repressive Effects of Resveratrol on Androgen Receptor Transcriptional Activity
por: Shi, Wen-feng, et al.
Publicado: (2009)

Neddylation regulation of mitochondrial structure and functions
por: Zhou, Qiyin, et al.
Publicado: (2021)

Orphan nuclear receptor TLX contributes to androgen insensitivity in castration-resistant prostate cancer via its repression of androgen receptor transcription
por: Jia, Lin, et al.
Publicado: (2018)

Association Between Neddylation and Immune Response
por: Zhu, Jiali, et al.
Publicado: (2022)

Anticancer drug discovery by targeting cullin neddylation
por: Yu, Qing, et al.
Publicado: (2020)

Mechanistic Support for Combined MET and AR Blockade in Castration-Resistant Prostate Cancer()()
por: Qiao, Yuanyuan, et al.
Publicado: (2016)

V-ATPase-dependent repression of androgen receptor in prostate cancer cells
por: Licon-Munoz, Yamhilette, et al.
Publicado: (2018)

PVT1 signals an androgen-dependent transcriptional repression program in prostate cancer cells and a set of the repressed genes predicts high-risk tumors
por: Videira, Alexandre, et al.
Publicado: (2021)

Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer
por: Speers, Corey, et al.
Publicado: (2017)

Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis
por: Tan, Mingjia, et al.
Publicado: (2016)

IL1β Expression Driven by Androgen Receptor Absence or Inactivation Promotes Prostate Cancer Bone Metastasis
por: DiNatale, Anthony, et al.
Publicado: (2022)

Overactivated neddylation pathway in human hepatocellular carcinoma
por: Yu, Jian, et al.
Publicado: (2018)

Androgen receptor is negatively correlated with the methylation-mediated transcriptional repression of miR-375 in human prostate cancer cells
por: CHU, MINGLIANG, et al.
Publicado: (2014)

Targeting the Neddylation Pathway to Suppress the Growth of Prostate Cancer Cells: Therapeutic Implication for the Men's Cancer
por: Wang, Xiaofang, et al.
Publicado: (2014)

Inhibition of neddylation regulates dendritic cell functions via Deptor accumulation driven mTOR inactivation
por: Cheng, Mengmeng, et al.
Publicado: (2016)

Neddylation dysfunction in Alzheimer's disease
por: Chen, Yuzhi, et al.
Publicado: (2012)

Neddylation and anti-tumor immunity
por: Wang, Xiaoguang, et al.
Publicado: (2021)

The p21-Dependent Radiosensitization of Human Breast Cancer Cells by MLN4924, an Investigational Inhibitor of NEDD8 Activating Enzyme
por: Yang, Dong, et al.
Publicado: (2012)

Suppression of tumor angiogenesis by targeting the protein neddylation pathway
por: Yao, W-T, et al.
Publicado: (2014)

Skp2 and Slug Are Coexpressed in Aggressive Prostate Cancer and Inhibited by Neddylation Blockade
por: Mickova, Alena, et al.
Publicado: (2021)

Functional and Oncological Outcomes Following Robot-Assisted and Laparoscopic Radical Prostatectomy for Localized Prostate Cancer With a Large Prostate Volume: A Retrospective Analysis With Minimum 2-Year Follow-Ups
por: Deng, Wen, et al.
Publicado: (2021)

BMI1 regulates androgen receptor in prostate cancer independently of the polycomb repressive complex 1
por: Zhu, Sen, et al.
Publicado: (2018)

Nucleolin represses transcription of the androgen receptor gene through a G-quadruplex
por: Miranti, Cindy K., et al.
Publicado: (2020)

Correction: Inhibition of neddylation regulates dendritic cell functions via Deptor accumulation driven mTOR inactivation
por: Cheng, Mengmeng, et al.
Publicado: (2018)

Androgen Receptor-Mediated Transcription in Prostate Cancer
por: Özturan, Doğancan, et al.
Publicado: (2022)

Interleukin‐6/signal transducer and activator of transcription 3 promotes prostate cancer resistance to androgen deprivation therapy via regulating pituitary tumor transforming gene 1 expression
por: Huang, Shengquan, et al.
Publicado: (2018)

Targeting neddylation sensitizes colorectal cancer to topoisomerase I inhibitors by inactivating the DCAF13-CRL4 ubiquitin ligase complex
por: Sun, Yilun, et al.
Publicado: (2023)

βKlotho inhibits androgen/androgen receptor-associated epithelial-mesenchymal transition in prostate cancer through inactivation of ERK1/2 signaling
por: Liu, Zhao, et al.
Publicado: (2018)

Discovery of neddylation E2s inhibitors with therapeutic activity
por: Mamun, MAA, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qdmljf117agfm5gcuuidkgvnsj